AstraZeneca Plans Local Job Cuts, Report Says

Xconomy Boston — 

London-based drug giant AstraZeneca (LON:AZN) plans to eliminate 113 jobs at its Westborough, MA, plant next month due to generic drug competition for its asthma drug budesonide (Plumicourt), the Boston Globe reports. Our Boston Tech Layoff Tracker has been updated accordingly. AstraZeneca also has a large R&D operation in Waltham, MA, where the company recently completed a major expansion to its facilities, according to the newspaper.